Phosphorylation of the cyclin CaPcl5 modulates both cyclin stability and specific recognition of the substrate

Einav Simon1, Tsvia Gildor, Daniel Kornitzer

  • 1Department of Molecular Microbiology, The Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa 31096, Israel.

Insights

The Candida albicans cyclin CaPcl5 activates Pho85 kinase, targeting transcription factor CaGcn4 for degradation. This cyclin also self-phosphorylates, leading to its own degradation and loss of substrate recognition, controlling its activity.

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Fungal Pathogenesis

Background:

  • Cyclins and cyclin-dependent kinases (CDKs) regulate the cell cycle.
  • The Candida albicans CaPcl5/Pho85 complex targets transcription factor CaGcn4 for degradation.
  • Understanding substrate specificity in cyclin-CDK interactions is crucial for cell cycle control.

Purpose of the Study:

  • To investigate the determinants of substrate selectivity for the CaPcl5/Pho85 complex.
  • To elucidate the regulatory mechanisms controlling CaPcl5 activity and stability.
  • To explore novel mechanisms for limiting cyclin activity in Candida albicans.

Main Methods:

  • Mutational analysis of Candida albicans cyclin CaPcl5.
  • In vitro biochemical assays to assess substrate recognition.
  • In vivo studies using ubiquitin ligase assays to determine degradation pathways.

Main Results:

  • Specific residues in the N-terminal region and cyclin box helix I of CaPcl5 are critical for substrate recognition.
  • CaPcl5 undergoes SCF(CDC4)-mediated self-phosphorylation and subsequent degradation in vivo.
  • In vitro phosphorylation of CaPcl5 leads to a loss of specific substrate recognition.

Conclusions:

  • CaPcl5's substrate selectivity is determined by specific residues within its cyclin box.
  • CaPcl5 self-phosphorylation serves as a dual regulatory mechanism, triggering degradation and reducing substrate binding.
  • This study reveals a novel mechanism for limiting cyclin activity, impacting cell cycle control in Candida albicans.

Related Concept Videos

Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...